G-quadruplex-mediated specific recognition, stabilization and transcriptional repression of bcl-2 by small molecule

Nirali Pandya1, Mamta Singh2, Reshma Rani3

  • 1Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, 453552, India.

Insights

A novel small molecule, BiGh, effectively targets the G-quadruplex structure in the bcl-2 oncogene promoter. This G-quadruplex stabilizer demonstrates high affinity and selectivity, offering a promising new avenue for anti-cancer therapeutics.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Oncology

Background:

  • The bcl-2 oncogene promotes cancer by inhibiting apoptosis and is overexpressed in many cancers.
  • Targeting the G-quadruplex (G4) structure in the bcl-2 promoter offers a potential therapeutic strategy.
  • Developing selective small molecules for G4 structures remains a challenge.

Purpose of the Study:

  • To identify and characterize a small molecule that selectively binds and stabilizes the bcl-2 G4 structure.
  • To evaluate the anti-cancer potential of the identified molecule through its effect on bcl-2 transcription and apoptosis.

Main Methods:

  • Synthesis and characterization of the small molecule 1,3-bis-(furan-2-yl-methylidene-amino) guanidine (BiGh).
  • Assessment of BiGh binding affinity and selectivity for bcl-2 G4 DNA using biophysical methods.
  • Evaluation of BiGh's effect on bcl-2 transcription, cell cycle, and apoptosis in cancer cells.
  • In silico ADME profiling for drug-likeness prediction.

Main Results:

  • BiGh exhibits very high affinity and selectivity for the bcl-2 G4 DNA structure over other G4s and duplex DNA.
  • BiGh stabilizes the bcl-2 G4 conformation, increasing thermal stability by up to 15°C.
  • BiGh significantly suppresses bcl-2 transcription and translation in cervical cancer cells via a G4-dependent mechanism, inducing cell cycle arrest and apoptosis.
  • In silico analysis suggests BiGh possesses favorable drug-like properties.

Conclusions:

  • BiGh is a potent and selective stabilizer of the bcl-2 G-quadruplex.
  • BiGh downregulates bcl-2 expression and exhibits anti-cancer activity, making it a promising lead compound for therapeutic development.
  • This study provides a foundation for developing G4 stabilizers with drug-like properties for cancer treatment.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K